首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry
【24h】

Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry

机译:使用稳定同位素标记的底物和液相色谱高分辨率质谱法测定组织中的黄嘌呤氧化还原酶活性

获取原文
获取原文并翻译 | 示例
           

摘要

Studies of pathological mechanisms and XOR inhibitor characterization, such as allopurinol, febuxostat, and topiroxostat, require accurate and sensitive measurements of XOR activity. However, the established assays have some disadvantages such as susceptibility to endogenous substances such as uric acid (UA), xanthine, or hypoxanthine. Here, we aimed to develop a novel XOR activity assay utilizing a combination of high-performance liquid chromatography (LC) and high-resolution mass spectrometry (HRMS) for tissues such as the liver, kidney, and plasma. Stable isotope-labeled [N-15(2)]-xanthine was utilized as substrate and the production of [N-15(2)]-uric acid was determined. [N-15(2)]-UA production by XOR was dependent on the amounts of [N-15(2)]-xanthine and enzyme and the time of reaction. Because high concentrations of endogenous xanthine and hypoxanthine affect XOR activities, we employed a multi-component analysis using LC/HRMS to improve the accuracy of XOR activity assay. Quantification of [N-15(2)]-UA was validated and showed good linearity, accuracy, and precision. We measured the XOR activities of retired ICR mice using [N-15(2)]-xanthine and LC/MS. The XOR activities in plasma, kidney, and liver samples were 38.1 +/- 0.7, 158 +/- 5,928 +/- 25 pmol/min/mg of protein, respectively (mean +/- SD, n = 5). Furthermore, we measured the XOR activities in the same samples using the LC/ultraviolet and LC/fluorescence (FL) methods. The level of [N-15(2)]-xanthine oxidation by XOR was equal to that of xanthine oxidation and approximately 7.9-8.9 times higher than that of pterin oxidation. We found a good correlation between XOR activities examined using LC/MS assay with [N-15(2)]-xanthine and those examined using LC/FL assay with pterin. This result suggested that although both the LC/MS assay with [N-15(2)]-xanthine and the LC/FL assay with pterin were useful, the former provided information regarding XOR activities that more directly reflected the physiological condition than the latter. (C) 2015 Elsevier B.V. All rights reserved.
机译:对病理机制和XOR抑制剂特性(例如别嘌醇,非布索坦和托泊司他)的研究要求对XOR活性进行准确而敏感的测量。然而,已建立的测定法具有一些缺点,例如对内源性物质如尿酸(UA),黄嘌呤或次黄嘌呤的敏感性。在这里,我们旨在开发一种结合了高效液相色谱(LC)和高分辨率质谱(HRMS)的新型XOR活性测定法,用于诸如肝脏,肾脏和血浆的组织。稳定的同位素标记的[N-15(2)]-黄嘌呤用作底物,并确定[N-15(2)]-尿酸的产量。通过XOR生成[N-15(2)]-UA取决于[N-15(2)]-黄嘌呤和酶的量以及反应时间。由于高浓度的内源性黄嘌呤和次黄嘌呤会影响XOR活性,因此我们使用LC / HRMS进行多组分分析以提高XOR活性测定的准确性。 [N-15(2)]-UA的定量得到验证,并显示出良好的线性,准确性和精确度。我们使用[N-15(2)]-黄嘌呤和LC / MS测量了退休ICR小鼠的XOR活性。血浆,肾脏和肝脏样品的XOR活性分别为38.1 +/- 0.7、158 +/- 5928 +/- 25 pmol / min / mg蛋白质(平均值+/- SD,n = 5)。此外,我们使用LC /紫外线和LC /荧光(FL)方法测量了相同样品中的XOR活性。通过XOR进行的[N-15(2)]-黄嘌呤氧化水平等于黄嘌呤氧化水平,比蝶呤氧化水平高约7.9-8.9倍。我们发现使用[N-15(2)]-黄嘌呤的LC / MS分析法检测的XOR活性与使用蝶呤的LC / FL分析法检测的XOR活性之间具有良好的相关性。该结果表明,尽管使用[N-15(2)]-黄嘌呤的LC / MS测定和使用蝶呤的LC / FL测定都有用,但前者提供的有关异或活性的信息比后者更直接反映了生理状况。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号